[1] Muntner, Paul, et al. “Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018.” JAMA 324.12 (2020): 1190-1200.
[2] Kreutz, Reinhold, et al. “2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.” European Journal of Internal Medicine 126 (2024): 1-15.
[3] McEvoy, John William, et al. “2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO).” European Heart Journal (2024): ehae178.
[4] Schmieder, Roland E., et al. “Improved persistence to medication, decreased cardiovascular events and reduced all-cause mortality in hypertensive patients with use of single-pill combinations: results from the START-Study.” Hypertension 80.5 (2023): 1127-1135.
[5] Liu, Jiamin, et al. “Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.” The Lancet 404.10449 (2024): 245-255.